Notice regarding Transfer of Asset and Recording of Gains
30 Sep 2024 //
PRESS RELEASE
Kewpie Releases Choline EX, New Food with Function Claims
20 Aug 2024 //
PRESS RELEASE
Kewpie Selected for FTSE4Good Index Series, Standard Index for ESG Investment
17 Jul 2024 //
PRESS RELEASE
Q2 Consolidated Financial Summary For FY Ending November 30, 2024
04 Jul 2024 //
PRESS RELEASE
Supplementary Data for the Second Quarter of the Fiscal Year Ending Nov 30, 2024
04 Jul 2024 //
PRESS RELEASE
Revised Forecasts: Consolidated Operating Results For FY Ending Nov 30, 2024
04 Jul 2024 //
PRESS RELEASE
Kewpie Introduces Bottles With 30% Recycled PET For All 180ml Dressings
02 Jul 2024 //
PRESS RELEASE
Kewpie Corporation Annual Report 2023
30 Apr 2024 //
PRESS RELEASE
Updated Consolidated Operating Results Forecast For FY Ending Nov 30, 2024
05 Apr 2024 //
PRESS RELEASE
Notice of Resolutions of the 111th Ordinary General Meeting of Shareholders
28 Feb 2024 //
PRESS RELEASE
Notice of the 111th Ordinary General Meeting of Shareholders
07 Feb 2024 //
PRESS RELEASE
Notice of Distribution of Retained Earnings
19 Jan 2024 //
PRESS RELEASE
Notice of Settlement of Accounts of Parent Company
19 Jan 2024 //
PRESS RELEASE
Matters Concerning Controlling Shareholder, Etc
19 Jan 2024 //
PRESS RELEASE
Sets up New Sales Company in Australia
10 Jan 2024 //
PRESS RELEASE
Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending November 30, 2023
05 Oct 2023 //
PRESS RELEASE
Kewpie Corporation Annual Report 2022
28 Apr 2023 //
PRESS RELEASE
Summary of Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending November 30
06 Apr 2023 //
PRESS RELEASE
FY2022 Financial Meeting Kewpie Corporation
02 Feb 2023 //
PRESS RELEASE
Notice of Settlement of Accounts of Parent Company, Etc
20 Jan 2023 //
PRESS RELEASE
Notice of Change in Major Shareholders
15 Nov 2022 //
PRESS RELEASE
A New Condiments Production Base in Tennessee, the U.S.
10 Nov 2022 //
PRESS RELEASE
Summary of Consolidated Financial Statements for the Third Quarter
07 Oct 2022 //
PRESS RELEASE
Notice regarding Revision of the Forecasts of Consolidated Operating Results
07 Jul 2022 //
PRESS RELEASE
Summary of Consolidated Financial Statements for the First Quarter
08 Apr 2022 //
PRESS RELEASE
Notice of Resolutions of the 109th Ordinary General Meeting of Shareholders
25 Feb 2022 //
PRESS RELEASE
Notice of the 109th Ordinary General Meeting
03 Feb 2022 //
PRESS RELEASE
Notice of Distribution of Retained Earnings
21 Jan 2022 //
PRESS RELEASE
Notice of Settlement of Accounts of Parent Company
21 Jan 2022 //
PRESS RELEASE
Summary of Consolidated Financial Statements for Fiscal Year Ended Nov 30, 2021
11 Jan 2022 //
PRESS RELEASE
Notice regarding Application for Selection of “Prime Market”in Market Segments
25 Nov 2021 //
PRESS RELEASE
The CHMP grants a positive opinion in the European Union on Deltyba
29 Jul 2021 //
BUSINESSWIRE
Japan`s Kewpie Corporation, Pioneer of the Hyaluronic Acid Revolution
29 Jul 2021 //
BUSINESSWIRE
Notice of the Progress of Acquisition by the Company of its Own Share
01 Mar 2021 //
PRESS RELEASE
Notice regarding Partial Sale of Shares Involving Change in Subsidiar
07 Jan 2021 //
PRESS RELEASE
Notice regarding Revision of the Forecasts of Consolidated Results November 30, 2020
30 Nov 2020 //
PRESS RELEASE
Summary of Consolidated Financial Statements for the 3Quarter Nov 30, 2020
30 Nov 2020 //
PRESS RELEASE
Notice regarding Revision of the Forecasts of Consolidated Operating Results
19 Nov 2020 //
PRESS RELEASE
FY2020 1H Financial Meeting
02 Jul 2020 //
PRESS RELEASE
The Kewpie Group Integrated Report 2020
06 Jun 2020 //
PRESS RELEASE
Systems to Secure the Properness of Business Activities Fundamental Policy
30 Nov 2014 //
PRESS RELEASE